ALBUNEX(R) ALBUMIN (HUMAN) 5%, SONICATED

FDA Premarket Approval P900059 S004

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for albunex(r). The device is indicated for use with transvaginal ultrasound to assess fallopian tube patency.

DeviceALBUNEX(R) ALBUMIN (HUMAN) 5%, SONICATED
Generic NameContrast Media, Ultrasound
ApplicantMOLECULAR BIOSYSTEMS, INC.
Date Received1996-09-03
Decision Date1997-06-17
Notice Date1997-09-23
PMAP900059
SupplementS004
Product CodeMJS 
Docket Number97M-0392
Advisory CommitteeRadiology
Supplement TypePanel Track
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product No
Applicant Address MOLECULAR BIOSYSTEMS, INC. 10030 Barnes Canyon Rd. san Diego, CA 92121

Supplemental Filings

Supplement NumberDateSupplement Type
P900059Original Filing
S004 1996-09-03 Panel Track
S003 1995-06-05 Normal 180 Day Track
S002 1994-11-02 Normal 180 Day Track
S001 1994-09-12 Special (immediate Track)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.